Your session is about to expire
← Back to Search
Other
Walnuts for Obesity
N/A
Waitlist Available
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participants will include adults ages 25-75 years with a BMI of > 30 kg/m2
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24-hour urine collections will occur at the end of each 3 week condition
Awards & highlights
Study Summary
This trial will test the effects of walnuts on the gut microbiota and inflammation in obese adults.
Who is the study for?
Adults aged 25-75 with obesity (BMI >30 kg/m2) who can deliver a fecal sample quickly after collection are eligible. Exclusions include those with walnut or food allergies, significant weight changes recently, substance abuse issues, certain medication use, recent surgeries affecting digestion or blood donation, diagnosed metabolic/gastrointestinal diseases, pregnancy/breastfeeding women, and uncontrolled diabetes or high blood pressure.Check my eligibility
What is being tested?
The trial is examining how adding walnuts or walnut oil to the diet of obese individuals affects their gut bacteria and inflammation levels. The study aims to see if these dietary changes can increase beneficial microbes that produce butyrate—a compound known to reduce inflammation.See study design
What are the potential side effects?
Since this trial involves consuming walnuts or walnut oil as part of the diet without any pharmaceutical intervention, side effects may be minimal but could include digestive discomfort for some participants.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 25 and 75 years old with a BMI over 30.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24-hour urine collections will occur at the end of each 3 week condition
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24-hour urine collections will occur at the end of each 3 week condition
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Concentration of fecal bile acids
Fecal Microbial Species
Secondary outcome measures
Fecal Microbial Metabolites
Other outcome measures
Fecal Microbiome
Inflammatory markers
Intestinal permeability
+2 moreTrial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention treatment oilExperimental Treatment1 Intervention
Intervention treatment will contain walnut oil in foods and be consumed everyday for 3 weeks.
Group II: Intervention treatmentExperimental Treatment1 Intervention
Intervention treatment will contain walnuts and be consumed everyday for 3 weeks.
Group III: Control treatmentPlacebo Group1 Intervention
Intervention treatment will contain corn oil in foods and be consumed everyday for 3 weeks.
Find a Location
Who is running the clinical trial?
University of Illinois at Urbana-ChampaignLead Sponsor
188 Previous Clinical Trials
37,305 Total Patients Enrolled
22 Trials studying Obesity
2,460 Patients Enrolled for Obesity
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 25 and 75 years old with a BMI over 30.I have a history of metabolic or gastrointestinal disease.I have recently been diagnosed with anemia.I have high blood sugar, high blood pressure, liver issues, or I'm on specific medications.I have not taken oral antibiotics in the last 6 weeks.I have had weight loss surgery or my gallbladder removed.
Research Study Groups:
This trial has the following groups:- Group 1: Control treatment
- Group 2: Intervention treatment
- Group 3: Intervention treatment oil
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this trial permitting individuals of a more advanced age to participate?
"As outlined in the criteria, individuals must be between 25 and 75 years old to enrol in this trial."
Answered by AI
Is this research study currently recruiting participants?
"As per the data on clinicaltrials.gov, this scientific research is currently recruiting participants. The experiment was first unveiled to the public on June 1st 2022 and underwent its last update 28 days later."
Answered by AI
What is the sample size of participants enrolled in this clinical research?
"Affirmative. Clinicaltrials.gov records confirm that this trial, initially posted on June 1st 2022, is actively recruiting patients. This medical study needs to find 27 people from one site for full participation."
Answered by AI
Is there any possibility I could join this experiment?
"Eligibility for this research requires patients to be between 25 and 75 years old with signs of inflammation. 27 individuals are currently being enrolled in the trial."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger